应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SYRS Syros Pharmaceuticals Inc.
盘后交易 08-15 16:45:36 EDT
1.53
-0.08
-5.26%
盘后
1.53
+0.00
0.00%
16:34 EDT
最高
1.70
最低
1.48
成交量
65.92万
今开
1.61
昨收
1.62
日振幅
13.62%
总市值
4,102万
流通市值
1,936万
总股本
2,681万
成交额
103.62万
换手率
5.21%
流通股本
1,265万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Syros Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.26%报1.70美元
自选股智能写手 · 08-15 21:46
Syros Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.26%报1.70美元
Syros Pharmaceuticals, Inc.盘中异动 股价大跌5.73%报1.81美元
自选股智能写手 · 08-14 22:01
Syros Pharmaceuticals, Inc.盘中异动 股价大跌5.73%报1.81美元
Syros Pharmaceuticals, Inc.股价重挫62.47% 市值跌3148.8万美元
自选股智能写手 · 08-13 21:32
Syros Pharmaceuticals, Inc.股价重挫62.47% 市值跌3148.8万美元
BUZZ--美国股票走势-Apollomics、Syros Pharmaceuticals、Buzzfeed
Reuters · 08-13 21:14
BUZZ--美国股票走势-Apollomics、Syros Pharmaceuticals、Buzzfeed
BUZZ-血癌疗法组合在研究中 "不太可能成功",Syros Pharma 公司业绩下滑
Reuters · 08-13 20:27
BUZZ-血癌疗法组合在研究中 "不太可能成功",Syros Pharma 公司业绩下滑
Syros Pharmaceuticals, Inc.盘中异动 急速跳水5.03%报4.91美元
自选股智能写手 · 08-10
Syros Pharmaceuticals, Inc.盘中异动 急速跳水5.03%报4.91美元
Syros Pharmaceuticals, Inc.盘中异动 股价大涨6.35%报5.53美元
自选股智能写手 · 08-06
Syros Pharmaceuticals, Inc.盘中异动 股价大涨6.35%报5.53美元
Syros Pharmaceuticals, Inc.2024财年第二财季实现净利润-23.33百万美元,同比增加35.66%
自选股智能写手 · 08-05
Syros Pharmaceuticals, Inc.2024财年第二财季实现净利润-23.33百万美元,同比增加35.66%
Syros Pharmaceuticals, Inc.盘中异动 临近收盘大幅下挫5.17%报5.69美元
自选股智能写手 · 08-02
Syros Pharmaceuticals, Inc.盘中异动 临近收盘大幅下挫5.17%报5.69美元
Syros Pharmaceuticals, Inc.盘中异动 下午盘急速上涨5.27%
自选股智能写手 · 08-01
Syros Pharmaceuticals, Inc.盘中异动 下午盘急速上涨5.27%
Syros Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.87%报6.85美元
自选股智能写手 · 07-30
Syros Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.87%报6.85美元
Syros Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌6.06%
自选股智能写手 · 07-23
Syros Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌6.06%
Syros Pharmaceuticals, Inc.盘中异动 急速拉升5.42%
自选股智能写手 · 07-11
Syros Pharmaceuticals, Inc.盘中异动 急速拉升5.42%
Syros Pharmaceuticals, Inc.盘中异动 股价大涨5.02%报5.44美元
自选股智能写手 · 07-10
Syros Pharmaceuticals, Inc.盘中异动 股价大涨5.02%报5.44美元
Syros Pharmaceuticals, Inc.盘中异动 临近收盘急速下跌5.04%
自选股智能写手 · 07-02
Syros Pharmaceuticals, Inc.盘中异动 临近收盘急速下跌5.04%
Syros Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.98%
自选股智能写手 · 06-28
Syros Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.98%
Syros Pharmaceuticals, Inc.盘中异动 股价大涨5.19%
自选股智能写手 · 06-14
Syros Pharmaceuticals, Inc.盘中异动 股价大涨5.19%
Syros Pharmaceuticals, Inc.盘中异动 急速下挫5.04%报5.37美元
自选股智能写手 · 05-23
Syros Pharmaceuticals, Inc.盘中异动 急速下挫5.04%报5.37美元
Syros Pharmaceuticals, Inc.2024财年第一财季实现净利润-3.71百万美元,同比增加84.41%
自选股智能写手 · 05-20
Syros Pharmaceuticals, Inc.2024财年第一财季实现净利润-3.71百万美元,同比增加84.41%
Syros Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.13%报5.37美元
自选股智能写手 · 05-14
Syros Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.13%报5.37美元
暂无数据
公司概况
公司名称:
Syros Pharmaceuticals Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Syros Pharmaceuticals, Inc.于2011年11月9日根据特拉华州法律注册成立。该公司是一家生物制药公司,致力于为血液系统恶性肿瘤患者的一线治疗制定新的护理标准。该公司正在推进一项后期临床计划,其中包括候选主要产品:(i)Tamibarotene,一种选择性视黄酸受体α激动剂,该公司正在进行SELECT-MDS-1,这是一项3期临床试验,评估达菲与阿扎胞苷联合治疗高危骨髓增生异常综合征(HR-MDS)患者的基因组定义子集。(ii)SY-2101,一种新的口服形式的三氧化二砷或ATO,其在新诊断的低风险急性早幼粒细胞白血病或APL患者的剂量确认研究中进行评估。
发行价格:
--
{"stockData":{"symbol":"SYRS","market":"US","secType":"STK","nameCN":"Syros Pharmaceuticals Inc.","latestPrice":1.53,"timestamp":1723752000000,"preClose":1.615,"halted":0,"volume":659164,"hourTrading":{"tag":"盘后","latestPrice":1.53,"preClose":1.53,"latestTime":"16:34 EDT","volume":4081,"amount":6289.609449199999,"timestamp":1723754085983},"delay":0,"floatShares":12654659,"shares":26809764,"eps":-3.875325,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.085,"latestTime":"08-15 16:45:36 EDT","open":1.61,"high":1.7,"low":1.48,"amount":1036218.3980324,"amplitude":0.136223,"askPrice":1.59,"askSize":1307,"bidPrice":1.48,"bidSize":10,"shortable":0,"etf":0,"ttmEps":-3.875325,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1723766400000},"adr":0,"listingDate":1467259200000,"adjPreClose":1.615,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.66,"preClose":1.615,"latestTime":"09:26 EDT","volume":14895,"amount":23486.841144,"timestamp":1723728370805},"postHourTrading":{"tag":"盘后","latestPrice":1.53,"preClose":1.53,"latestTime":"16:34 EDT","volume":4081,"amount":6289.609449199999,"timestamp":1723754085983},"volumeRatio":0.445205,"impliedVol":3.1906,"impliedVolPercentile":0.9683},"requestUrl":"/m/hq/s/SYRS/tweets","defaultTab":"tweets","newsList":[{"id":"2459747803","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.26%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459747803","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459747803?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:46","pubTimestamp":1723729611,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时46分,Syros Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.26%。截至发稿,该股报1.70美元/股,成交量14.2622万股,换手率0.53%,振幅4.95%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.48%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081521465197198d17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081521465197198d17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","BK4139","SYRS"],"gpt_icon":0},{"id":"2459177115","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大跌5.73%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459177115","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459177115?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:01","pubTimestamp":1723644074,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时01分,Syros Pharmaceuticals, Inc.股票出现波动,股价快速下挫5.73%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.49%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc.涨幅较大,Genprex, Inc.、Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.较为活跃,换手率分别为80.91%、64.01%、47.79%,振幅较大的相关个股有Genprex, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为58.52%、48.32%、44.00%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142201149682639b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142201149682639b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","SYRSW","BK4139"],"gpt_icon":0},{"id":"2459390604","title":"Syros Pharmaceuticals, Inc.股价重挫62.47% 市值跌3148.8万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459390604","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459390604?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:32","pubTimestamp":1723555928,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时32分,Syros Pharmaceuticals, Inc.股票出现异动,股价快速下挫62.47%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Cardio Diagnostics Holdings Inc C/Wts To Pur Com、冠科美博、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Genprex, Inc.、冠科美博、Psyence Biomedical Ltd.较为活跃,换手率分别为107.01%、66.64%、18.33%,振幅较大的相关个股有冠科美博、Jaguar Health, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为21.54%、15.12%、10.94%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132099f278dbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132099f278dbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","SYRS","BK4139"],"gpt_icon":0},{"id":"2459905783","title":"BUZZ--美国股票走势-Apollomics、Syros Pharmaceuticals、Buzzfeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2459905783","media":"Reuters","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459905783?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:14","pubTimestamp":1723554893,"startTime":"0","endTime":"0","summary":"** 西方石油公司 :盘前下跌 1.9** Devon Energy Corp :盘前下跌 0.1** EQT Corp :盘前下跌 0.3%BUZZ - BMO 下调了石油和天然气生产商的目标价 ** Uranium Energy Corp :盘前上涨1.0%BUZZ - 怀俄明州重启生产后上涨 ** 星巴克 :盘前上涨14.2%BUZZ--任命Chipotle的顶头上司Brian Niccol为首席执行官后跳涨 ** Syros Pharmaceuticals :盘前下跌 61.9%BUZZ - 血液癌症治疗组合在研究中 \"不太可能成功\",导致其下滑 ** Hudbay Minerals Inc :盘前下跌4.2%BUZZ - 因第二季度亏损扩大而下跌 ** Apollomics Inc :盘前上涨 120.3%BUZZ - 因癌症治疗研究的初步数据良好而上涨","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAX","LU0211328371.USD","JBLU","BK4585","BK4587","SYRS","BK4570","LU1074936037.SGD","LU0354030438.USD","NVAX","LU0251143029.SGD","IE00B19Z4B17.USD","DVN","DE","SG9999014484.SGD","APLM","BK4077","LU1201861249.SGD","BK4142","LU1674673428.USD","GCTS","LU0079474960.USD","EQT","MRNS","LU1778281490.HKD","LU1551013425.SGD","LU2756315664.SGD","SBUX","HLT","LU0868494708.USD","LU0942090050.USD","RILY","BK4023","LU0323240290.USD","CVX","LU1674673691.USD","LU2211817866.USD","SAVA","BZFD","SG9999002679.SGD","NOVA","BK4588","LUNR","GB00BDT5M118.USD","BK4592","LU0211327993.USD","HD","SG9999013486.USD","WULF","LU0980610538.SGD"],"gpt_icon":1},{"id":"2459197095","title":"BUZZ-血癌疗法组合在研究中 \"不太可能成功\",Syros Pharma 公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2459197095","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459197095?lang=zh_cn&edition=full","pubTime":"2024-08-13 20:27","pubTimestamp":1723552033,"startTime":"0","endTime":"0","summary":"** SYRS表示,目前已加入该研究的患者将有机会继续参与试验,具体由研究人员决定。** SYRS还在骨髓增生异常综合征患者中测试这种疗法,骨髓增生异常综合征是指骨髓中的造血细胞出现异常时发生的一类癌症。** 截至上一交易日收盘,SYRS 在今年累计下跌约 36","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1023059063.AUD","IE00B2B36J28.USD","LU0170899867.USD","LU1244550221.USD","LU0310799852.SGD","LU0689472784.USD","LU0122379950.USD","LU1093756168.USD","LU0943347566.SGD","LU0211327993.USD","BK4533","LU0310800379.SGD","LU0661504455.SGD","ABBV","LU0795875169.SGD","LU1003077747.HKD","LU1093756325.SGD","BK4139","LU1267930490.SGD","IE00B4R5TH58.HKD","LU0820561909.HKD","IE00BJT1NW94.SGD","BK4559","IE0004445239.USD","LU0198837287.USD","LU0114720955.EUR","LU1061106388.HKD","LU0256863811.USD","LU0211328371.USD","BK4534","IE00BJJMRZ35.SGD","LU0128525929.USD","SYRS","LU1244550577.SGD","IE0002141913.USD","LU1267930573.SGD","BUZZ","LU0708994859.HKD","LU0553294199.USD","LU1496350171.SGD","IE0009355771.USD","BK4550","IE00BFTCPJ56.SGD","BK4588","LU0912757837.SGD","BK4566","LU0820561818.USD","LU1057294990.SGD","LU0882574055.USD"],"gpt_icon":0},{"id":"2458951684","title":"Syros Pharmaceuticals, Inc.盘中异动 急速跳水5.03%报4.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458951684","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458951684?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:22","pubTimestamp":1723220562,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日00时22分,Syros Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.03%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.75%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大,Azitra Inc、Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为416.18%、88.44%、65.49%,振幅较大的相关个股有Azitra Inc、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为90.93%、62.57%、37.04%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810002242941ffc6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810002242941ffc6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRS","SYRSW"],"gpt_icon":0},{"id":"2457288280","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大涨6.35%报5.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457288280","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457288280?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:37","pubTimestamp":1722951466,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时37分,Syros Pharmaceuticals, Inc.股票出现异动,股价快速拉升6.35%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Sangamo Therapeutics, Inc.涨幅较大,Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为863.29%、438.59%、225.86%,振幅较大的相关个股有Vbi Vaccines, Inc.、Actinium Pharmaceuticals, Inc. 、Briacell Therapeutics Corp C/Wts 24/02/2025,振幅分别为135.14%、27.81%、26.16%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213747af963383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213747af963383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","BK4139","SYRSW"],"gpt_icon":0},{"id":"2457538137","title":"Syros Pharmaceuticals, Inc.2024财年第二财季实现净利润-23.33百万美元,同比增加35.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457538137","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457538137?lang=zh_cn&edition=full","pubTime":"2024-08-05 00:16","pubTimestamp":1722788193,"startTime":"0","endTime":"0","summary":"8月5日,Syros Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第二财季净利润为-23.33百万美元,同比增加35.66%;其中营业收入为0.00美元,每股基本收益为-0.59美元。机构评级:截至2024年8月5日,当前有4家机构对Syros Pharmaceuticals, Inc.目标价做出预测,其中目标均价为19.25美元,其中最低目标价为12.00美元,最高目标价为37.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408050016429f0dcff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408050016429f0dcff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","SYRS"],"gpt_icon":0},{"id":"2456695234","title":"Syros Pharmaceuticals, Inc.盘中异动 临近收盘大幅下挫5.17%报5.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456695234","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456695234?lang=zh_cn&edition=full","pubTime":"2024-08-02 03:48","pubTimestamp":1722541693,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日03时48分,Syros Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.17%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃,换手率分别为3070.00%、397.10%、222.92%,振幅较大的相关个股有Dermata Therapeutics, Inc.、Renovaro Inc.、Virax Biolabs Group Limited,振幅分别为59.30%、57.88%、43.37%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080203481396822cb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080203481396822cb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRSW","SYRS"],"gpt_icon":0},{"id":"2456166442","title":"Syros Pharmaceuticals, Inc.盘中异动 下午盘急速上涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456166442","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456166442?lang=zh_cn&edition=full","pubTime":"2024-08-01 02:43","pubTimestamp":1722451434,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日02时43分,Syros Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.27%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.12%。其相关个股中,Molecular Partners Ag、Alpha Tau Medical Ltd C/Wts 、木薯科学涨幅较大,Cns Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Imunon, Inc.较为活跃,换手率分别为720.48%、168.56%、154.23%,振幅较大的相关个股有Molecular Partners Ag、Renovaro Inc.、Alpha Tau Medical Ltd C/Wts ,振幅分别为89.73%、79.10%、52.94%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801024354aefc7f86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801024354aefc7f86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","BK4139","SYRS"],"gpt_icon":0},{"id":"2455958749","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.87%报6.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455958749","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455958749?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:46","pubTimestamp":1722347198,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时46分,Syros Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.87%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.19%。其相关个股中,Imunon, Inc.、Processa Pharmaceuticals, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃,换手率分别为1068.87%、827.07%、740.35%,振幅较大的相关个股有Imunon, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Processa Pharmaceuticals, Inc.,振幅分别为59.66%、49.31%、45.29%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730214638aefc341f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730214638aefc341f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","BK4139","SYRS"],"gpt_icon":0},{"id":"2453790350","title":"Syros Pharmaceuticals, Inc.盘中异动 临近午盘股价大跌6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453790350","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453790350?lang=zh_cn&edition=full","pubTime":"2024-07-23 00:00","pubTimestamp":1721664024,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日00时00分,Syros Pharmaceuticals, Inc.股票出现异动,股价快速跳水6.06%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Mei Pharma, Inc.较为活跃,换手率分别为119.05%、109.10%、63.95%,振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学,振幅分别为44.07%、34.27%、33.41%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230000249681eee3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407230000249681eee3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRS","SYRSW"],"gpt_icon":0},{"id":"2450580845","title":"Syros Pharmaceuticals, Inc.盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450580845","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450580845?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:49","pubTimestamp":1720630169,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日00时49分,Syros Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.42%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.14%。其相关个股中,Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Longeveron Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃,换手率分别为3946.61%、1460.97%、1134.06%,振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.,振幅分别为421.88%、133.16%、119.83%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110049299681b970&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110049299681b970&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","SYRSW","BK4139"],"gpt_icon":0},{"id":"2450020414","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大涨5.02%报5.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450020414","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450020414?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:31","pubTimestamp":1720542666,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时31分,Syros Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.02%。截至发稿,该股报5.44美元/股,成交量4.795万股,换手率0.18%,振幅5.75%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.35%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100031079681b31a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100031079681b31a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","SYRS","BK4139"],"gpt_icon":0},{"id":"2448823942","title":"Syros Pharmaceuticals, Inc.盘中异动 临近收盘急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448823942","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448823942?lang=zh_cn&edition=full","pubTime":"2024-07-02 03:45","pubTimestamp":1719863122,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日03时45分,Syros Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.04%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.80%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。消息层面,截至03时45分,《Form 144 | Syros Pharmaceuticals董事拟出售3.48万股股份,价值约19.93万美元》资讯为影响Syros Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702034523af900c15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702034523af900c15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRS","SYRSW"],"gpt_icon":0},{"id":"2446368516","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446368516","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446368516?lang=zh_cn&edition=full","pubTime":"2024-06-28 22:00","pubTimestamp":1719583230,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日22时00分,Syros Pharmaceuticals, Inc.股票出现波动,股价快速下跌6.98%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。消息层面,截至22时00分,《JMP Securities维持Syros Pharmaceuticals买入评级,维持目标价12美元》资讯为影响Syros Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628220031aef72a5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628220031aef72a5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRS","SYRSW"],"gpt_icon":0},{"id":"2443634238","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443634238","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443634238?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:51","pubTimestamp":1718301091,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时51分,Syros Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.19%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,Longeveron Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、乌龙制药涨幅较大,Longeveron Inc.、Biorestorative Therapies, Inc.、Cero Therapeutics Holdings, Inc.较为活跃,换手率分别为2629.27%、1282.95%、148.31%,振幅较大的相关个股有Longeveron Inc.、Cero Therapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为102.21%、82.05%、74.62%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061401513196814100&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061401513196814100&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRSW","SYRS"],"gpt_icon":0},{"id":"2437435902","title":"Syros Pharmaceuticals, Inc.盘中异动 急速下挫5.04%报5.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437435902","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437435902?lang=zh_cn&edition=full","pubTime":"2024-05-23 04:00","pubTimestamp":1716408038,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日04时00分,Syros Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.04%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Effector Therapeutics Inc C/Wts 31/12/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Gt Biopharma, Inc.较为活跃,换手率分别为365.05%、181.62%、61.00%,振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Mustang Bio, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 ,振幅分别为74.26%、65.74%、57.14%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523040038941e97a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523040038941e97a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRS","SYRSW"],"gpt_icon":0},{"id":"2436198415","title":"Syros Pharmaceuticals, Inc.2024财年第一财季实现净利润-3.71百万美元,同比增加84.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436198415","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436198415?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:07","pubTimestamp":1716134845,"startTime":"0","endTime":"0","summary":"3月31日,Syros Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第一财季净利润为-3.71百万美元,同比增加84.41%;其中营业收入为0.00美元,每股基本收益为-0.10美元。机构评级:截至2024年3月31日,当前有4家机构对Syros Pharmaceuticals, Inc.目标价做出预测,其中目标均价为19.25美元,其中最低目标价为12.00美元,最高目标价为37.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200007358b185ecc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200007358b185ecc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","SYRSW"],"gpt_icon":0},{"id":"2435190535","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.13%报5.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435190535","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435190535?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:43","pubTimestamp":1715694198,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时43分,Syros Pharmaceuticals, Inc.股票出现异动,股价快速上涨6.13%。截至发稿,该股报5.37美元/股,成交量7419股,换手率0.03%,振幅3.56%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。Syros Pharmaceuticals, Inc.公司简介:Syros Pharmaceuticals Inc 是一家生物制药公司,致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421431887e87d02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421431887e87d02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","SYRSW","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.syros.com","stockEarnings":[{"period":"1week","weight":-0.6776},{"period":"1month","weight":-0.737},{"period":"3month","weight":-0.7053},{"period":"6month","weight":-0.7751},{"period":"1year","weight":-0.5761},{"period":"ytd","weight":-0.7927}],"compareEarnings":[{"period":"1week","weight":0.0484},{"period":"1month","weight":-0.0317},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0886},{"period":"1year","weight":0.2277},{"period":"ytd","weight":0.144}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Syros Pharmaceuticals, Inc.于2011年11月9日根据特拉华州法律注册成立。该公司是一家生物制药公司,致力于为血液系统恶性肿瘤患者的一线治疗制定新的护理标准。该公司正在推进一项后期临床计划,其中包括候选主要产品:(i)Tamibarotene,一种选择性视黄酸受体α激动剂,该公司正在进行SELECT-MDS-1,这是一项3期临床试验,评估达菲与阿扎胞苷联合治疗高危骨髓增生异常综合征(HR-MDS)患者的基因组定义子集。(ii)SY-2101,一种新的口服形式的三氧化二砷或ATO,其在新诊断的低风险急性早幼粒细胞白血病或APL患者的剂量确认研究中进行评估。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008745},{"month":2,"riseRate":0.5,"avgChangeRate":-0.093448},{"month":3,"riseRate":0.5,"avgChangeRate":0.03661},{"month":4,"riseRate":0.375,"avgChangeRate":-0.022337},{"month":5,"riseRate":0.625,"avgChangeRate":0.031071},{"month":6,"riseRate":0.625,"avgChangeRate":0.041503},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.018345},{"month":8,"riseRate":0.666667,"avgChangeRate":0.059332},{"month":9,"riseRate":0.25,"avgChangeRate":-0.10985},{"month":10,"riseRate":0.125,"avgChangeRate":-0.226094},{"month":11,"riseRate":0.375,"avgChangeRate":-0.005364},{"month":12,"riseRate":0.375,"avgChangeRate":0.20216}],"exchange":"NASDAQ","name":"Syros Pharmaceuticals Inc.","nameEN":"Syros Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Syros Pharmaceuticals Inc.(SYRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Syros Pharmaceuticals Inc.(SYRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Syros Pharmaceuticals Inc.,SYRS,Syros Pharmaceuticals Inc.股票,Syros Pharmaceuticals Inc.股票老虎,Syros Pharmaceuticals Inc.股票老虎国际,Syros Pharmaceuticals Inc.行情,Syros Pharmaceuticals Inc.股票行情,Syros Pharmaceuticals Inc.股价,Syros Pharmaceuticals Inc.股市,Syros Pharmaceuticals Inc.股票价格,Syros Pharmaceuticals Inc.股票交易,Syros Pharmaceuticals Inc.股票购买,Syros Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Syros Pharmaceuticals Inc.(SYRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Syros Pharmaceuticals Inc.(SYRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}